TY - JOUR
T1 - Gambling disorder in the UK
T2 - key research priorities and the urgent need for independent research funding
AU - Bowden-Jones, Henrietta
AU - Hook, Roxanne W
AU - Grant, Jon E
AU - Ioannidis, Konstantinos
AU - Corazza, Ornella
AU - Fineberg, Naomi A
AU - Singer, Bryan F
AU - Roberts, Amanda
AU - Bethlehem, Richard
AU - Dymond, Simon
AU - Romero-Garcia, Rafa
AU - Robbins, Trevor W
AU - Cortese, Samuele
AU - Thomas, Shane A
AU - Sahakian, Barbara J
AU - Dowling, Nicki A
AU - Chamberlain, Samuel R
N1 - Copyright © 2022 Elsevier Ltd. All rights reserved.
PY - 2022/4
Y1 - 2022/4
N2 - Gambling in the modern era is pervasive owing to the variety of gambling opportunities available, including those that use technology (eg, online applications on smartphones). Although many people gamble recreationally without undue negative effects, a sizeable subset of individuals develop disordered gambling, which is associated with marked functional impairment including other mental health problems, relationship problems, bankruptcy, suicidality, and criminality. The National UK Research Network for Behavioural Addictions (NUK-BA) was established to promote understanding of, research into, and treatments for behavioural addictions including gambling disorder, which is the only formally recognised behavioural addiction. In this Health Policy paper, we outline the status of research and treatment for disordered gambling in the UK (including funding issues) and key research that should be conducted to establish the magnitude of the problem, vulnerability and resilience factors, the underlying neurobiology, long-term consequences, and treatment opportunities. In particular, we emphasise the need to: (1) conduct independent longitudinal research into the prevalence of disordered gambling (including gambling disorder and at-risk gambling), and gambling harms, including in vulnerable and minoritised groups; (2) select and refine the most suitable pragmatic measurement tools; (3) identify predictors (eg, vulnerability and resilience markers) of disordered gambling in people who gamble recreationally, including in vulnerable and minoritised groups; (4) conduct randomised controlled trials on psychological interventions and pharmacotherapy for gambling disorder; (5) improve understanding of the neurobiological basis of gambling disorder, including impulsivity and compulsivity, genetics, and biomarkers; and (6) develop clinical guidelines based on the best contemporary research evidence to guide effective clinical interventions. We also highlight the need to consider what can be learnt from approaches towards mitigating gambling-related harm in other countries.
AB - Gambling in the modern era is pervasive owing to the variety of gambling opportunities available, including those that use technology (eg, online applications on smartphones). Although many people gamble recreationally without undue negative effects, a sizeable subset of individuals develop disordered gambling, which is associated with marked functional impairment including other mental health problems, relationship problems, bankruptcy, suicidality, and criminality. The National UK Research Network for Behavioural Addictions (NUK-BA) was established to promote understanding of, research into, and treatments for behavioural addictions including gambling disorder, which is the only formally recognised behavioural addiction. In this Health Policy paper, we outline the status of research and treatment for disordered gambling in the UK (including funding issues) and key research that should be conducted to establish the magnitude of the problem, vulnerability and resilience factors, the underlying neurobiology, long-term consequences, and treatment opportunities. In particular, we emphasise the need to: (1) conduct independent longitudinal research into the prevalence of disordered gambling (including gambling disorder and at-risk gambling), and gambling harms, including in vulnerable and minoritised groups; (2) select and refine the most suitable pragmatic measurement tools; (3) identify predictors (eg, vulnerability and resilience markers) of disordered gambling in people who gamble recreationally, including in vulnerable and minoritised groups; (4) conduct randomised controlled trials on psychological interventions and pharmacotherapy for gambling disorder; (5) improve understanding of the neurobiological basis of gambling disorder, including impulsivity and compulsivity, genetics, and biomarkers; and (6) develop clinical guidelines based on the best contemporary research evidence to guide effective clinical interventions. We also highlight the need to consider what can be learnt from approaches towards mitigating gambling-related harm in other countries.
KW - COMPULSIVITY
KW - DOUBLE-BLIND
KW - IMAGINAL DESENSITIZATION
KW - IMPULSE CONTROL DISORDERS
KW - METAANALYSIS
KW - NALTREXONE
KW - PREVALENCE
KW - RISK
KW - SEEKING
KW - VALIDATION
U2 - 10.1016/S2215-0366(21)00356-4
DO - 10.1016/S2215-0366(21)00356-4
M3 - (Systematic) Review article
C2 - 35180386
SN - 2215-0374
VL - 9
SP - 321
EP - 329
JO - Lancet Psychiatry
JF - Lancet Psychiatry
IS - 4
ER -